EyePoint, Inc. Additional Paid in Capital, Common Stock
EyePoint, Inc. (EYPT) had Additional Paid in Capital, Common Stock of $1.45 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-05
- 2026-06-30: Additional Paid in Capital, Common Stock $1.45B.
- 2026-03-31: Additional Paid in Capital, Common Stock $1.42B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.41B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.24B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $1.45B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $1.42B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.41B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $1.24B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.22B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.22B 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.21B 10-K · filed 2026-03-05 | |
| 2024-09-30 | $1.05B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.03B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.02B 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.01B 10-K · filed 2025-03-06 | |
| 2023-09-30 | $785.79M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $771.82M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $770.03M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $766.90M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $763.56M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $760.21M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $756.07M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $752.60M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $641.54M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $638.97M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $637.80M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $528.36M 10-K · filed 2022-03-14 | |
| 2020-09-30 | $501.83M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $494.63M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $493.97M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $472.76M 10-K · filed 2021-03-12 | $472.67M 10-K · filed 2020-03-16 |
| 2019-09-30 | $469.87M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $466.49M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $446.67M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $445.19M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $443.67M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $374.77M 10-KT · filed 2019-03-18 | |
| 2018-03-31 | $336.87M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $331.61M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $324.93M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $323.28M 10-KT · filed 2019-03-18 | |
| 2017-03-31 | $316.23M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $313.35M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $312.95M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $312.21M 10-K · filed 2017-09-13 | |
| 2016-03-31 | $311.46M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $294.29M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $293.47M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $293.06M 10-K · filed 2016-09-13 | |
| 2014-06-30 | $290.86M 10-K · filed 2015-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |